OBJECTIVE: The purpose of this study was to investigate treatment of uterine leiomyoma by hysterectomy and uterine conserving procedures (UCPs). STUDY DESIGN: Data from Kaiser Permanente Northern California members undergoing hysterectomy, myomectomy, uterine artery embolization (UAE) and endometrial ablation (EA) for uterine leiomyoma from 1997-2003 were collected. Statistical analysis included trend tests and survival analysis. RESULTS: Hysterectomy rates for leiomyoma decreased significantly from 2.13 per 1000 to 1.91 (P < .0001). Rates for myomectomy (.4-.37) and EA (.26-.27) remained stable (P = .17 and .26, respectively), whereas rates for UAE increased significantly from < .01-.24 (P < .0001). The combined rates for hysterectomy and UCPs remained stable at 2.79 (P = .95). Rate of hysterectomy after UCP increased over time, and at 6 years reached 11.5%, 17.7%, and 7.9% for EA, UAE, and myomectomy, respectively. CONCLUSION: Whereas rate of hysterectomy for leiomyoma decreased, total rate of invasive treatment remained stable. Increase in rate of UAE had the greatest impact on treatment, possibly replacing hysterectomy.
OBJECTIVE: The purpose of this study was to investigate treatment of uterine leiomyoma by hysterectomy and uterine conserving procedures (UCPs). STUDY DESIGN: Data from Kaiser Permanente Northern California members undergoing hysterectomy, myomectomy, uterine artery embolization (UAE) and endometrial ablation (EA) for uterine leiomyoma from 1997-2003 were collected. Statistical analysis included trend tests and survival analysis. RESULTS: Hysterectomy rates for leiomyoma decreased significantly from 2.13 per 1000 to 1.91 (P < .0001). Rates for myomectomy (.4-.37) and EA (.26-.27) remained stable (P = .17 and .26, respectively), whereas rates for UAE increased significantly from < .01-.24 (P < .0001). The combined rates for hysterectomy and UCPs remained stable at 2.79 (P = .95). Rate of hysterectomy after UCP increased over time, and at 6 years reached 11.5%, 17.7%, and 7.9% for EA, UAE, and myomectomy, respectively. CONCLUSION: Whereas rate of hysterectomy for leiomyoma decreased, total rate of invasive treatment remained stable. Increase in rate of UAE had the greatest impact on treatment, possibly replacing hysterectomy.
Authors: Katharina Maria Edler; Karl Tamussino; Gerhard Fülöp; Evi Reinstadler; Walter Neunteufel; Philipp Reif; Rene Laky; Thomas Aigmüller Journal: Geburtshilfe Frauenheilkd Date: 2017-05-24 Impact factor: 2.915
Authors: Johnathan C Chung; Dingxin Wang; Robert J Lewandowski; Richard Tang; Howard B Chrisman; Robert L Vogelzang; Gayle E Woloschak; Andrew C Larson; Reed A Omary; Robert K Ryu Journal: J Magn Reson Imaging Date: 2010-05 Impact factor: 4.813
Authors: Timothy I Richardson; Christian A Clarke; Kuo-Long Yu; Ying K Yee; Thomas J Bleisch; Jose E Lopez; Scott A Jones; Norman E Hughes; Brian S Muehl; Charles W Lugar; Terry L Moore; Pamela K Shetler; Richard W Zink; John J Osborne; Chahrzad Montrose-Rafizadeh; Nita Patel; Andrew G Geiser; Rachelle J Sells Galvin; Jeffrey A Dodge Journal: ACS Med Chem Lett Date: 2010-12-09 Impact factor: 4.345
Authors: Mark A Hayden; Zehra Ordulu; C Scott Gallagher; Bradley J Quade; Raymond M Anchan; Nia Robinson Middleton; Serene S Srouji; Elizabeth A Stewart; Cynthia C Morton Journal: Cancer Genet Date: 2018-02-19
Authors: Vanessa L Jacoby; Alison Jacoby; Lee A Learman; Michael Schembri; Steven E Gregorich; Rebecca Jackson; Miriam Kuppermann Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-09-16 Impact factor: 2.435
Authors: Eric D Levens; Clariss Potlog-Nahari; Alicia Y Armstrong; Robert Wesley; Ahalya Premkumar; Diana L Blithe; Wendy Blocker; Lynnette K Nieman Journal: Obstet Gynecol Date: 2008-05 Impact factor: 7.661
Authors: Bijan J Borah; Shannon K Laughlin-Tommaso; Evan R Myers; Xiaoxi Yao; Elizabeth A Stewart Journal: Obstet Gynecol Date: 2016-01 Impact factor: 7.661